Transplantation Society is located in null. The organization was established in 1974. According to its NTEE Classification (G90) the organization is classified as: Medical Disciplines, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Transplantation Society is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Transplantation Society generated $2.0m in total revenue. The organization has seen a slow decline revenue. Over the past 7 years, revenues have fallen by an average of (0.1%) each year. All expenses for the organization totaled $1.8m during the year ending 12/2021. As we would expect to see with falling revenues, expenses have declined by (3.5%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Transplantation Society has awarded 14 individual grants totaling $333,710. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
INTERNATIONAL LEADERSHIP IN THE SCIENCE, EDUCATION, ETHICS AND PRACTICE OF TRANSPLANTATION.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PROGRAM AND MAGAZINE PUBLICATIONS INCLUDING WEBSITE DEVELOPMENT AND WEBINARS AVAILABLE TO MEMBERS ONLY. THESE PUBLICATIONS RELATE SPECIFICALLY TO THE FIELD OF ORGAN TRANSPLANTATION.
AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION -GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. THE MEDAWAR PRIZE IS UNIVERSALLY CONSIDERED TO BE COMMENSURATE WITH THE MOST OUTSTANDING WORLD PRIZES FOR SCIENTIFIC ACHIEVEMENT. 2) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 3)TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION.
EVENTS HELD IN A VARIETY OF GLOBAL VENUES WHERE MEMBERS OF THE COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. ORGAN TRANSPLANTATION IS A SUCCESSFUL THERAPY FOR END STAGE ORGAN FAILURE OF THE KIDNEY, LIVER, HEART, LUNG, PANCREAS AND INTESTINE. TRANSPLANTATION OF CELLS AND TISSUES ALSO TRANSFORMED THE THERAPEUTIC OPTIONS FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISEASE, EYE DISEASE AND ORTHOPAEDIC DISEASE, AND HAS THE POTENTIAL TO ALTER SIGNIFICANTLY THETHERAPEUTIC OPTIONS FOR PATIENTS WITH DIABETES AND A RANGE OF DISORDERS. THE ACCESS OF PATIENTS TO TRANSPLANTATION THERAPY VARIES WIDELY ACROSS THE GLOBE, PARTLY DETERMINED BY THE UNDERLYING LEVEL OF ECONOMIC DEVELOPMENT IN DIFFERENT STATES AND PARTLY DETERMINED BY OTHER FACTORS SUCH AS THE AVAILABILITY OF ORGAN, CELL AND TISSUE DONORS, OR THE SPECIALIZED PROVISION OF HEALTH SERVICES. THE ORGANIZATION HAS DETERMINED THAT IT WILL SEEK TO ADDRESS GLOBAL INEQUITIES IN TRANSPLANTATION THERAPY, IN ORDER TO FACILITATE APPROPRIATE ACCESS TO TRANSPLANTATION FOR ALL PATIENTS WHO WOULD BENEFIT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Jean-Pierre Mongeau Executive Director(thru 10/21) | Officer | 40 | $111,768 |
Marcelle Mcphaden Exec. Director (eff. 10/21) | Officer | 40 | $30,003 |
Dr Mehmet Haberal Immediate Past-President | OfficerTrustee | 1 | $0 |
Dr Marcelo Cantarovich President-Elect | OfficerTrustee | 2 | $0 |
Gabriel E Gondolesi Officer | OfficerTrustee | 1 | $0 |
Minnie Sarwal Senior Treasurer | OfficerTrustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Jj Editorial Llc Journal Management | 12/30/20 | $225,836 |
Wolters Kluwer Health Inc Journal Management | 12/30/20 | $146,253 |
Quality Meetings Event Management | 12/30/20 | $110,249 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $228,613 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $152,750 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $381,363 |
Total Program Service Revenue | $1,230,488 |
Investment income | $236,788 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $164,497 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,013,136 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $28,345 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $50,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $141,771 |
Compensation of current officers, directors, key employees. | $141,771 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $413,226 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $49,197 |
Payroll taxes | $66,982 |
Fees for services: Management | $20,175 |
Fees for services: Legal | $2,446 |
Fees for services: Accounting | $42,801 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $56,235 |
Fees for services: Other | $0 |
Advertising and promotion | $1,795 |
Office expenses | $56,002 |
Information technology | $51,063 |
Royalties | $0 |
Occupancy | $99,631 |
Travel | $13,971 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $50,125 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $14,672 |
Insurance | $1,072 |
All other expenses | $6,112 |
Total functional expenses | $1,809,433 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $3,507,043 |
Savings and temporary cash investments | $159,754 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $416,504 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $60,756 |
Net Land, buildings, and equipment | $68,310 |
Investments—publicly traded securities | $11,150,247 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $15,362,614 |
Accounts payable and accrued expenses | $1,361,453 |
Grants payable | $0 |
Deferred revenue | $1,398,060 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $4,701 |
Other liabilities | $62,319 |
Total liabilities | $2,826,533 |
Net assets without donor restrictions | $11,418,626 |
Net assets with donor restrictions | $1,117,455 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $15,362,614 |
Over the last fiscal year, Transplantation Society has awarded $106,190 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
Cranford, NJ PURPOSE: SPONSORSHIP OF WORKS | $56,190 |
Tucson, AZ PURPOSE: SPONSORSHIP OF WORKS | $25,000 |
Somerville, MA PURPOSE: PROFESSORSHIP FUND | $25,000 |
Organization Name | Assets | Revenue |
---|---|---|
Joseph Rowntree Foundation | $422,657,604 | $8,163,690 |
American School Of Milan | $34,975,339 | $18,900,429 |
Shalva Israel Assoc To Relieve The Handicapped Child And Family | $89,694,654 | $19,416,096 |
Cuso International | $17,986,190 | $25,338,532 |
West Africa Rice Development Association | $23,999,248 | $19,439,683 |
Merton College | $449,219,486 | $18,363,821 |
Cooperativa De Ahorro Y Credito De Vega Alta | $355,977,126 | $21,743,565 |
Ivey Business School Foundation | $20,172,840 | $19,210,645 |
Tula Foundation | $43,438,708 | $5,288,962 |
Allgemeine Anthroposophische | $21,895,649 | $16,689,603 |
Master & Fellows Of Peterhouse | $470,069,266 | $14,639,374 |
Bermuda Institute Of Ocean Sciences Bios Inc | $48,144,596 | $11,893,948 |